Management Board

krzysztof-kaczmarczyk

Krzysztof
Kaczmarczyk

Chief Executive Officer

Manager with over 20 years of experience in investment banks and international corporations.

 

In 1999-2008 Krzysztof Kaczmarczyk worked for Deutsche Bank conducting market analyses in Central and Eastern Europe. In 2008-2010 he held management positions in Telekomunikacja Polska Group and Orange Group and was responsible for strategy and business development. In 2010-2011 he worked at Credit Suisse, a Swiss investment bank. From 2012 to 2015, he served as Vice President of the Supervisory Board for Strategy and Development at Emitel, an operator of terrestrial radio and television network in Poland. In 2016-2019 he served as Advisor to the Supervisory Board of KGHM Polska Miedź S.A. for Strategy and Development.

In parallel, he gained over 15 years of supervisory experience as member of supervisory boards of companies listed on the WSE. Since 2006 Krzysztof Kaczmarczyk has been a member of supervisory boards of more than 30 companies including: Action, Alta, Arteria, Braster, BEST, BSC Drukarnia, Celon Pharma, CI Games CP Energia, Develia, Duon, Emitel, Elektrotim, Enel Med, Enter Air, European Copper Institute, TP Edukacja i Wypoczynek, Warsaw Stock Exchange, Graal, Integer, InPost, Info-TV-Operator, KGHM Polska Miedź, KGHM International, KGHM TFI, Mabion, Magellan, Nextbike, Polimex-Mostostal, Polish Energy Partners, Robyg, RS TV, SARE, TIM, Vigo System, Wirtualna Polska, Work Service, 4fun Media.

Krzysztof Kaczmarczyk is a graduate of the Warsaw School of Economics (SGH) with a degree in Finance and Accounting. He also studied International Relations at the University of Warsaw.

Responsibilities

He manages the work of the Management Board and coordinates the work of other Management Board members. The main tasks of the President of the Management Board include developing the Company’s business strategy and investment policy as well as attracting business and strategic partners. The President of the Management Board is also responsible for risk management, the area of information obligations and investor relations, and supervising the correct execution of the Company’s operational and financial activities.

grzegorz-grabowicz

Grzegorz
Grabowicz

Chief Financial Officer

Experienced CFO in companies listed on the WSE, statutory auditor, working with companies from the financial and medical industry since 2003. 

 

As of January 2019, he has been a Member of the Management Board and Chief Financial Officer at the Company. He gained knowledge and experience in management successively working: in 1998-2003 in the Audit Department at Deloitte, in 2003-2017 he was Vice President of the Management Board and Chief Financial Officer at Magellan S.A. (currently BFF Polska S.A.). At the same time, in the years 2010-2013, he was the President of the Management Board of MEDFinance S.A. and in the years 2007-2017 he was a member of the Supervisory Board of Magellan Czech Republic and Magellan Slovakia. In the years 2013-2017 he was the Chairman of the Supervisory Board of MEDFinance S.A. Grzegorz Grabowicz was a member of the following Supervisory Boards of companies listed on the WSE: Skarbiec Holding S.A.; Develia S.A. (former LC Corp S.A.); Medicalgorithmics S.A. Currently, he is a member of the Supervisory Board of PRAGMAGO S.A. and X-Trade Brokers Dom Maklerski S.A.

He graduated from the University of Lodz, Faculty of Management and Marketing, specializing in Accounting, obtaining a Master’s degree in Management and Marketing. In 2010 he completed a program organized by Nottingham Trent University and obtained the title of EMBA (Executive Master of Business Administration). He is a Certified Auditor.

Responsibilities

He is responsible for supervising and managing the financial policy of the Company. He is responsible for arranging, financing, and negotiating the Company’s significant financial transactions and creating financial plans of the Company and its financial reporting.

slawomir-jaros

Dr eng. Sławomir
Jaros, EMBA

Chief Operations Officer and Chief Scientific Officer

A manager and scientist, doctor of biotechnology, author of numerous scientific publications, involved in building the team and technology of Mabion from the beginning of its operation.  

 

Graduate of the Warsaw University of Life Sciences majoring in Biotechnology. He received his Ph.D. in biological sciences with honors in the development of an innovative vaccine against Fasciola hepatica in recombinant protein and nucleic acid technology at the National Academy of Sciences in Warsaw. He is a graduate of the Polish-American Executive MBA Program, organized by the University of Maryland and the University of Lodz from which he graduated with the best student award. Author and co-author of several dozen scientific publications in the field of biotechnology. Since 2015 he is regularly invited by the Medical University of Lodz to give original lectures on, among others, the development of biosimilar drugs.

Scope of responsibility

As a member of the Management Board, he is responsible for supervising, managing and integrating the following areas in the Company: drug design, technology development and analytics, the area of clinical trials and occupational safety and pharmaceutical risk control. His responsibilities include cooperation with external partners in the technological, scientific and commercial areas and the development of strategies for new products and technologies. He is also responsible for the area of manufacturing, quality control and quality assurance and for the implementation of technological and analytical processes into the pharmaceutical environment, process scale-up, quality, time and cost optimization of processes, as well as manufacturing process supervision and operations management.

MicrosoftTeams-image (19)

Adam
Pietruszkiewicz

Chief Commercial Officer

Extensive expertise in the area of business scale development, an extensive list of completed strategic projects in the region of Central and Eastern Europe. 

 

A graduate of Boston University, where he majored in international management and international relations. He has over 20 years of experience in the private equity industry: he led the Polish operations of the Coast2Coast Capital fund, and before that, for over 13 years, he was associated with The Riverside Company fund, where he also served as a managing director. While investing and developing companies from various industries (including healthcare, IT, industrial, food) he built a network of strong contacts in the business environment in our country and in the entire region of Central and Eastern Europe.

In the period starting 16 June 2020, Mr. Adam Pietruszkiewicz, in his capacity as Member of the Supervisory Board of Mabion S.A., was delegated twice by the Supervisory Board to act as Member of the Management Board, for the first time from 17 September 2020 to 17 December 2020 and then from 25 January 2021 until the date of his resignation from the Supervisory Board due to his appointment to the Management Board of the Company.

Responsibilities

Within the Board Adam Pietruszkiewicz is responsible for the business development of the Company, strategic projects and acquisition of new partners. It was at Adam’s initiative that the business relationship with Novavax was established.

Supervisory Board

Robert Koński Chairman of the Board, Independent Member of the Board

 

Graduate of the John F. Kennedy School of Government (MPA) at Harvard University and Tufts University (BA) in the United States. Since March 2020, he has been the President of the Supervisory Board and a Partner in the consulting company Five Rand Sp. z o.o. In recent years, he has worked for PGE Polska Grupa Energetyczna S.A., Kulczyk Holding S.A., Euronet Worldwide, Inc., and Horton International, among others. In 1990-1995, he served as advisor to the Minister of Finance (from Leszek Balcerowicz to Grzegorz Kołodko) on the transformation and restructuring of the Polish financial services sector; he was also a member of the team negotiating the agreement with the London Club. Currently, he serves on the Supervisory Board of Platige Image S.A. Robert Koński meets the independence criteria referred to in Rule II.Z.4 of the document “Code of Best Practice for WSE Listed Companies 2021”.

 

Robert Koński has knowledge of accounting and auditing and is skilled in the industry in which Mabion operates.

Józef Banach Independent Member of the Supervisory Board

 

Graduate of the Faculty of Law of the Jagiellonian University in Kraków. Legal Counselor. Managing Partner at InCorpore Banach Szczypiński Partners. He started his career at the Ministry of Finance and then worked for PricewaterhouseCoopers sp. z o.o. for several years, most recently as the leader of the Proceedings and International Tax Law team. Member of a number of supervisory boards of capital companies, including, among others, Chairman of the Supervisory Board of Poczta Polska S.A. and PHN S.A. For many years an expert of the Tax Council of the Polish Confederation of Private Employers Lewiatan, including acting Head of the Tax Council. Author of numerous publications in the field of law, including the commentary “Polskie umowy o unikaniu podwójnego opodatkowania” [Polish agreements on avoiding double taxation] published by CH Beck. He repeatedly represented parties in proceedings before administrative authorities and administrative and common courts, which ended with the client’s success. Józef Banach meets the independence criteria referred to in principle II.Z.4 of the document “Code of Best Practice for WSE Listed Companies 2021”.

 

Józef Banach has knowledge of accounting and auditing and is skilled in the industry in which Mabion operates.

David John James Independent Member of the Supervisory Board

 

Graduate of Cambridge University, Chartered Accountant with the Polish Chamber of Chartered Accountants and ICAEW (Institute of Chartered Accountants in England and Wales). Currently International Liaison Partner at Grupa Strategia, Poland. He has 28 years of experience in audit and internal control. Member of the supervisory boards of many companies and an advisor in the scope of establishing business in the region of Central and Eastern Europe for nearly fifty companies. Partner responsible for auditing financial statements of more than 100 companies and groups of companies from various business sectors, both listed companies, private equity funds and family businesses. He has conducted over 80 due diligence analyses, dealt with statutory, internal and forensic financial audits and provided business advisory services to a number of clients.

 

He has worked in Poland, UK, Germany, Czech Republic, Slovakia and Russia. He is fluent in eight languages and can communicate in twelve other. For four years, David James mentored about 100 teams of young entrepreneurs participating in the Cambridge Python Project. Within this project, organized under the aegis of the British Embassy and the University of Cambridge, David James trained students from all over Poland in creating modern business plans and budgeting. David James is the creator of an original method of learning foreign languages. He meets the independence criteria referred to in Rule II.Z.4 of the document “Best Practices of WSE Listed Companies 2021”.

 

David James has knowledge and skills in accounting / auditing.

Wojciech Wośko Member of the Supervisory Board

 

Graduate of the Faculty of Medicine at the Medical University of Lodz and Postgraduate Studies in Management Accounting at the University of Lodz. Licensed securities broker (license No. 449). Associated with the capital market since 1994. Worked for HSBC Securities Polska, Dom Maklerski BZ WBK, Santander Biuro Maklerskie where he was responsible for sales to institutional clients (investment funds, pension funds, asset management companies). He is competent in conducting transactions on the domestic and foreign cash and derivatives markets. He participated in the preparation and conduct of numerous public offerings of companies on the primary and secondary market. Since July 2020 he has been working for Polfarmex S.A.

Sławomir Kościak Independent Member of the Supervisory Board

 

Licensed Investment Advisor with license number 303 and holder of the CFA (Chartered Financial Analyst) title. Graduated from Warsaw School of Economics with a major in Finance and Banking, also studied at Aarhus School of Business in Denmark and Universität zu Köln in Germany, completed the Community of European Management Schools –Master’s in International Management (CEMS MIM) management program. Scholarship holder of the Educational Enterprise Foundation. He conducted classes on courses for stock brokers (ZMiD) and for investment advisors (PERK). He has over 10 years of experience in asset management. He has worked, among others, for the European Investment Fund in Luxembourg and the Morgan Stanley real estate fund in Frankfurt. In 2009-2020 he managed a number of different funds and investment strategies within TFI PZU, both with PZU Group’s own money and with money entrusted by external clients, equity, mixed and absolute return funds. The investment spectrum included companies listed on the WSE as well as those listed on stock exchanges in the EU and the USA. Member of the investment committee, AUM over PLN 20 billion. Since 2014 as a Medical Sector Director in TFI PZU he was responsible for investments in companies from the health care sector.

Sławomir Kościak meets the independence criteria referred to in principle II.Z.4 of the document “Code of Best Practice for WSE Listed Companies 2021”.

Zofia Szewczuk Independent Member of the Supervisory Board

 

A graduate of ESCP-EAP Europe and the Poznań University of Economics with a degree in Finance and Accounting and a Master’s degree in Management. She has over 12 years of experience in the private equity industry, which she gained working in leading funds in Poland and abroad. Since 2016 she has been associated with the Polish Development Fund S.A., where she currently serves as Office Director in the Investment Department of PFR S.A. and President of the Supervisory Board of PFR Life Science Sp. z o.o., a company specializing in investments in the field of biotechnology and health. She gained previous experience in funds such as Mid Europa (2011-2015) and 3i (2009-2011). During this time, she had the opportunity to participate in numerous transactions in sectors such as new technologies, services, manufacturing, health and tourism.

 

Zofia Szewczuk has extensive ownership and supervisory experience, representing the investor side. Her input involves regular cooperation with the supervisory boards of companies in implementing development and remedial initiatives and monitoring their performance. Currently she is a member of the Supervisory Board of Polskie Kolei Linowe S.A. and an observer in HCP company. MsZofia Szewczuk meets the independence criteria referred to in principle II.Z.4 of the document “Code of Best Practice for WSE Listed Companies 2021”.

 

Zofia Szewczuk has knowledge of accounting and auditing and is skilled in the industry in which Mabion operates.

Committees

Audit Committee

 

David John James
Chairman of the Audit Committee

Józef Banach

Robert Koński

Sławomir Kościak

Zofia Szewczuk

Appointment and Remuneration Committee

 

Robert Koński
Chairman of the Appointment and Remuneration Committee

David John James

Józef Banach

Wojciech Wośko